2014年5月20日 · In women, kidney and bladder cancers are the 11th and 15th most common cancers and together account for 4.6% of total malignancies and 3.7% of malignancy-related …

The risk of a urological cancer, especially urothelial malignancy, after normal hematuria clinic investigations is very low. All visible hematuria representations should be re-investigated, …

hematuria is the most common presenting sign of urologic malignancies that may lead to early diagnosis and cure of these cancers.2 In 2001, the American Urology Association reported …

2020年10月1日 · Patients presenting with microhematuria represent a heterogeneous population with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific …

To calculate the prevalence of renal cell carcinoma (RCC), upper urinary tract urothelial carcinoma (UT-UC), and lower urinary tract urothelial carcinoma (LT-UC) in patients with gross …

The incidence of urological malignancies, primarily bladder and kidney cancers, diagnosed following the evaluation of hematuria varies from 2–5% in the setting of AMH in referred …

• With microscopic hematuria in patients at low risk of cancer, performing repeat urinalysis at six months is a reasonable alternative to imaging and cystoscopy. • Although gross hematuria is...

2011年5月1日 · Older age (greater than 40 years OR 17.0, 95% CI 11.2–25.7), greater hematuria (greater than 25 red blood cells per high power field OR 4.0, 95% CI 3.5–4.5) and male gender …

2019年10月18日 · The most severe and devastating consequence of hematuria is malignancy. Many classifications exist to stratify patients into low-, intermediate-, and high-risk; a …

Malignancy is identified in approximately 3-5% of patients presenting with asymptomatic microhematuria and 23% of patients presenting with gross hematuria. Following an …